ATE529125T1 - Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung - Google Patents
Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilungInfo
- Publication number
- ATE529125T1 ATE529125T1 AT04745067T AT04745067T ATE529125T1 AT E529125 T1 ATE529125 T1 AT E529125T1 AT 04745067 T AT04745067 T AT 04745067T AT 04745067 T AT04745067 T AT 04745067T AT E529125 T1 ATE529125 T1 AT E529125T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- pharmaceutical compositions
- wound healing
- accelerating wound
- accelerating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49300003P | 2003-08-07 | 2003-08-07 | |
PCT/IL2004/000727 WO2005013885A2 (en) | 2003-08-07 | 2004-08-05 | Pharmaceutical compositions and methods for accelerating wound healing |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE529125T1 true ATE529125T1 (de) | 2011-11-15 |
Family
ID=34135191
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04745067T ATE529125T1 (de) | 2003-08-07 | 2004-08-05 | Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung |
Country Status (14)
Country | Link |
---|---|
US (4) | US7638484B2 (de) |
EP (1) | EP1651161B1 (de) |
JP (2) | JP4668902B2 (de) |
CN (2) | CN101287483B (de) |
AT (1) | ATE529125T1 (de) |
AU (1) | AU2004263009B2 (de) |
CA (1) | CA2535029C (de) |
DK (1) | DK1651161T3 (de) |
ES (1) | ES2375565T3 (de) |
HK (2) | HK1091400A1 (de) |
NZ (1) | NZ545086A (de) |
RU (2) | RU2358753C2 (de) |
WO (1) | WO2005013885A2 (de) |
ZA (1) | ZA200601089B (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040037828A1 (en) | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
US20030148924A1 (en) * | 2002-07-09 | 2003-08-07 | Tamar Tennenbaum | Methods and pharmaceutical compositions of healing wounds |
US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
NZ545086A (en) | 2003-08-07 | 2011-06-30 | Healor Ltd | Pharmaceutical compositions and methods for accelerating wound healing |
CA2542142A1 (en) * | 2003-10-09 | 2005-05-19 | Trustees Of Boston University | Methods and compositions using adiponectin for treatment of cardiac disorders and for stimulation of angiogenesis |
EP2298864B1 (de) | 2004-03-22 | 2017-10-11 | Mesoblast International Sàrl | Mesenchymale stammzellen und deren verwendungen |
JP2006230316A (ja) * | 2005-02-25 | 2006-09-07 | Japan Health Science Foundation | 瘢痕のない創傷治癒能を有する細胞およびその調製方法 |
US8367606B2 (en) * | 2005-08-29 | 2013-02-05 | Healor Ltd. | Method and compositions for prevention and treatment of diabetic and aged skin |
KR100888889B1 (ko) | 2007-07-24 | 2009-03-17 | 부산대학교 산학협력단 | 비스파틴을 유효성분으로 함유하는 혈관신생 촉진제 |
CN101835486B (zh) * | 2007-07-30 | 2012-12-12 | 希尔洛有限公司 | 用于治疗创伤的药物组合物以及相关方法 |
WO2009025866A1 (en) * | 2007-08-23 | 2009-02-26 | Intrexon Corporation | Methods and compositions for diagnosing disease |
JP2010540534A (ja) * | 2007-09-28 | 2010-12-24 | イントレキソン コーポレーション | 生体治療分子の発現のための治療遺伝子スイッチ構築物およびバイオリアクター、ならびにその使用 |
AU2009201915C1 (en) | 2008-08-22 | 2015-02-26 | Regeneus Ltd | Therapeutic methods |
RU2573912C2 (ru) | 2008-10-08 | 2016-01-27 | Интрексон Корпорейшн | Сконструированные клетки, экспрессирующие множественные иммуномодуляторы, и их применения |
WO2010117170A2 (ko) * | 2009-04-06 | 2010-10-14 | 주식회사 뉴로테크 | 화상 손상의 치료 또는 예방용 약학 조성물 |
US8173154B2 (en) * | 2010-01-06 | 2012-05-08 | The Curators Of The University Of Missouri | Boron trioxide glass-based fibers and particles in dressings, sutures, surgical glue, and other wound care compositions |
CA2789972A1 (en) | 2010-01-11 | 2011-07-14 | Healor Ltd. | Method for treatment of inflammatory disease and disorder |
EP2637684A4 (de) * | 2010-11-08 | 2014-05-07 | Healor Ltd | Gepufferte ophthalmische zusammensetzungen und verwendungsverfahren dafür |
US10279007B2 (en) | 2010-11-15 | 2019-05-07 | Oxygenetix Institute, Inc. | Topical treatment method for healing wounds, disinfecting, covering and concealing the wound until healing occurs |
US9730964B2 (en) * | 2011-03-15 | 2017-08-15 | Cell Ideas Pty Ltd. | Pharmaceutical compositions and topical use thereof |
AU2013203165B2 (en) * | 2011-03-15 | 2015-02-26 | Cell Ideas Pty Ltd | Pharmaceutical compositions and topical use thereof |
AU2015202776B2 (en) * | 2011-03-15 | 2017-08-17 | Cell Ideas Pty Ltd | Pharmaceutical compositions and topical use thereof |
US20140220598A1 (en) * | 2011-09-09 | 2014-08-07 | Tohoku University | Biological substance detection method |
EP2863927A4 (de) | 2012-06-26 | 2015-12-02 | Rusty Property Holdings Pty Ltd | Zusammensetzungen und verfahren zur verringerung der frequenz und/oder der schwere von kopfschmerzen |
JP6113981B2 (ja) * | 2012-06-29 | 2017-04-12 | ポーラ化成工業株式会社 | スクリ−ニング方法 |
KR101588394B1 (ko) * | 2013-05-09 | 2016-01-25 | 라정찬 | 줄기세포의 재생능 향상을 위한 배지 조성물 및 이를 이용한 줄기세포의 배양방법 |
ES2821813T3 (es) | 2014-03-31 | 2021-04-27 | Lubrizol Advanced Mat Inc | Extracto de fermentación de una cepa bacteriana para el aumento de los niveles de adiponectina |
KR20160010212A (ko) | 2014-07-18 | 2016-01-27 | 주식회사 젬백스앤카엘 | 항노화 및 창상 치료용 펩티드 및 이를 포함하는 조성물 |
EP3090764A1 (de) * | 2015-05-08 | 2016-11-09 | Université Catholique De Louvain | Zusammensetzungen mit mesenchymalen stammzellen und verwendungen davon |
CN107847558B (zh) * | 2015-07-31 | 2021-05-04 | 宝血纯化科技股份有限公司 | 用于促进伤口愈合的组合物 |
WO2017027353A1 (en) * | 2015-08-07 | 2017-02-16 | The Johns Hopkins University | Compositions and methods for modulating wound healing and regeneration |
EP3132809A1 (de) * | 2015-08-21 | 2017-02-22 | Bioskinco GmbH | Zusammensetzung und produkte mit alterungszellen zur geweberegeneration |
JP6952761B2 (ja) * | 2016-03-24 | 2021-10-20 | ステムラボ,エスエイ | 組織修復のための臍帯血由来エキソソームの使用 |
CN106215172A (zh) * | 2016-07-28 | 2016-12-14 | 广州赛莱拉干细胞科技股份有限公司 | 一种改善伤口愈合的脂肪制剂及其制备方法 |
CN106177919A (zh) * | 2016-07-28 | 2016-12-07 | 广州赛莱拉干细胞科技股份有限公司 | 一种改善伤口愈合的脂肪制剂及其制备方法 |
EP3595680A1 (de) | 2017-03-17 | 2020-01-22 | Rutgers, The State University of New Jersey | Zusammensetzungen und verfahren zur wundheilung |
RU2663907C1 (ru) * | 2017-05-04 | 2018-08-13 | Ринат Маратович Урузбаев | Способ ускорения заживления кожных повреждений |
MX2020000029A (es) * | 2017-07-05 | 2020-08-06 | Jiangyin Mucocare Pharmaceutical Co Ltd | Formulaciones topicas que comprenden montelukast y combinaciones con proteinas adhesivas del mejillon. |
RU2687007C2 (ru) * | 2017-09-12 | 2019-05-06 | Общество с ограниченной ответственностью "Клеточные Системы" | Способ биотехнологического восстановления кожного покрова аллогенными стволовыми клетками человека |
CN109876012B (zh) * | 2019-03-21 | 2022-01-11 | 北京隆祺生物科技有限公司 | 一种药用组合物及其在促进皮肤伤口愈合中的应用 |
CN113304174A (zh) * | 2020-03-30 | 2021-08-27 | 大树医疗美容科技(广州)有限公司 | 一种人体脂肪细胞分泌的培养液提取物 |
US20230137248A1 (en) * | 2021-10-28 | 2023-05-04 | Kismet Technologies Llc | Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control |
Family Cites Families (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2001A (en) * | 1841-03-12 | Sawmill | ||
US200A (en) * | 1837-05-22 | Geoege | ||
US2003A (en) * | 1841-03-12 | Improvement in horizontal windivhlls | ||
GB280460A (en) | 1927-06-10 | 1927-11-17 | George Percival Milnes | Improvements in mouthpieces for tobacco pipes and other tubes |
US3549747A (en) | 1968-02-20 | 1970-12-22 | Flow Pharma Inc | Contact lens wetting solution and method of using same |
US3856919A (en) | 1970-06-08 | 1974-12-24 | Burton Parsons Chemicals Inc | Ophthalmic solution |
US3947573A (en) | 1969-12-01 | 1976-03-30 | Burton, Parsons And Company, Inc. | Opthalmic solution |
US3767788A (en) | 1970-06-08 | 1973-10-23 | Burton Parsons Chemicals Inc | Ophthalmic solution |
US3767789A (en) | 1971-06-21 | 1973-10-23 | Burton Parsons & Co Inc | Method of providing a synthetic mucus in vivo |
US3907985A (en) | 1973-07-27 | 1975-09-23 | Burton Parsons And Company Inc | Polystyrene sulfonate containing opthalmic solutions |
US3987163A (en) | 1973-07-27 | 1976-10-19 | Burton, Parsons And Company, Inc. | Polystyrene sulfonate containing opthalmic solutions |
US4029817A (en) | 1973-09-24 | 1977-06-14 | Allergan Pharmaceuticals | Soft contact lens preserving solutions |
US3920810A (en) | 1974-04-23 | 1975-11-18 | Burton Parsons And Company Inc | Polyacrylamide containing ophthalmic solutions |
US4120949A (en) | 1977-10-05 | 1978-10-17 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4131651A (en) | 1977-10-25 | 1978-12-26 | Barnes-Hind Pharmaceuticals, Inc. | Treatment of dry eye |
US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4558033A (en) * | 1983-06-06 | 1985-12-10 | Amgen | Potentiation of the effects of insulin by peptides |
US4673649A (en) * | 1983-07-15 | 1987-06-16 | University Patents, Inc. | Process and defined medium for growth of human epidermal keratinocyte cells |
WO1985005036A1 (en) | 1984-04-30 | 1985-11-21 | The Trustees Of Columbia University In The City Of | Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch |
US5110801A (en) | 1984-08-13 | 1992-05-05 | Leveen Harry H | Treatment of acne |
US4666828A (en) | 1984-08-15 | 1987-05-19 | The General Hospital Corporation | Test for Huntington's disease |
US4801531A (en) | 1985-04-17 | 1989-01-31 | Biotechnology Research Partners, Ltd. | Apo AI/CIII genomic polymorphisms predictive of atherosclerosis |
US4843096A (en) | 1985-06-26 | 1989-06-27 | Stiefel Laboratories, Inc. | Treatment of acne |
US4940660A (en) * | 1985-11-25 | 1990-07-10 | Wako Pure Chemical Industries | Color developing method in clinical examinations |
US4833257A (en) * | 1986-07-28 | 1989-05-23 | Arizona Board Of Regents | Compositions of matter and methods of using same |
IL80298A (en) | 1986-10-14 | 1993-01-31 | Res & Dev Co Ltd | Eye drops |
JPH0739508B2 (ja) * | 1986-11-11 | 1995-05-01 | 株式会社林原生物化学研究所 | プルラン・ポリエチレングリコ−ル会合物とその製造方法並びに用途 |
US4885163A (en) | 1987-02-24 | 1989-12-05 | Eli Lilly And Company | Topical use of IGF-II for wound healing |
US4808402A (en) * | 1987-05-29 | 1989-02-28 | Northwestern University | Method and compositions for modulating neovascularization |
US5700450A (en) | 1988-03-30 | 1997-12-23 | The Trustees Of Boston University | Methods for enhancing melanin synthesis in melanocytes using diacyglycerols and uses thereof |
ZA892928B (en) | 1988-04-25 | 1991-01-30 | Pro Neuron Inc | Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
US5137734A (en) * | 1989-03-22 | 1992-08-11 | Dana Farber Cancer Institute | Angiogenic monoglycerides |
US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
US5158935A (en) * | 1989-05-12 | 1992-10-27 | Chiron Corporation | Human epidermal growth factor having substitution at position 11 |
US5723119A (en) * | 1989-07-28 | 1998-03-03 | Schering Corporation | Method for enhancing wound healing/repair with IL-4 |
US5145679A (en) * | 1989-10-05 | 1992-09-08 | Hinson Joan B | Topical emollient for prevention and treatment of circulatory induced lesions |
US5423778A (en) * | 1989-12-14 | 1995-06-13 | Elof Eriksson | System and method for transplantation of cells |
US5981606A (en) * | 1991-03-01 | 1999-11-09 | Warner-Lambert Company | Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same |
SK108293A3 (en) | 1991-04-11 | 1994-09-07 | Schering Corp | Anti-tumor and anti-psoriatic agents |
DE69229779T2 (de) * | 1991-04-19 | 1999-12-23 | Lds Technologies Inc | Konvertierbare mikroemulsionsverbindungen |
HUT67319A (en) * | 1991-08-30 | 1995-03-28 | Life Medical Sciences Inc | Compositions for treating wounds |
US5591709A (en) * | 1991-08-30 | 1997-01-07 | Life Medical Sciences, Inc. | Compositions and methods for treating wounds |
WO1993008825A1 (en) * | 1991-11-04 | 1993-05-13 | Zymogenetics, Inc. | Pdgf gel formulation |
US6537973B1 (en) | 1992-03-16 | 2003-03-25 | Isis Pharmaceuticals, Inc. | Oligonucleotide inhibition of protein kinase C |
DE4208552A1 (de) | 1992-03-17 | 1993-09-23 | Liedtke Pharmed Gmbh | Topische arzneiformen mit insulin |
GB9210574D0 (en) * | 1992-05-18 | 1992-07-01 | Ca Nat Research Council | Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications |
CA2125060C (en) | 1993-07-02 | 1999-03-30 | Henry P. Dabrowski | Ophthalmic solution for artificial tears |
DE69531712T2 (de) * | 1994-04-25 | 2004-07-01 | Japan Science And Technology Corp., Kawaguchi | Hybridgel, das eine biologisch aktive Substanz sekretiert |
US6028118A (en) * | 1996-08-08 | 2000-02-22 | Les Laboratoires Aeterna Inc. | Methods of using extracts of shark cartilage |
JP3414539B2 (ja) | 1994-05-11 | 2003-06-09 | 有限会社ドット | 経鼻吸収用組成物 |
RU2161489C2 (ru) | 1994-05-24 | 2001-01-10 | Еда Рисерч энд Дивелопмент Ко. Лтд. | Усовершенствованный сополимер-1 в сополимерных композициях |
JP4624495B2 (ja) | 1994-12-29 | 2011-02-02 | フェリング・インターナショナル・センター・エス.・エー. | ヒト・インスリンの生成 |
AUPN089295A0 (en) | 1995-02-02 | 1995-03-02 | International Diabetes Institute | Treatment of diabetic neuropathy |
US5631245A (en) * | 1995-06-06 | 1997-05-20 | Biodynamics Pharmaceuticals, Inc. | Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions |
GB2304047A (en) | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
US6455247B1 (en) * | 1996-01-23 | 2002-09-24 | Board Of Trustees Of The Leland Stanford Junior University | Methods for screening for transdominant effector peptides and RNA molecules |
US5869037A (en) * | 1996-06-26 | 1999-02-09 | Cornell Research Foundation, Inc. | Adenoviral-mediated gene transfer to adipocytes |
JPH10158188A (ja) | 1996-11-29 | 1998-06-16 | Senju Pharmaceut Co Ltd | 角膜治療用組成物 |
GB9702943D0 (en) * | 1997-02-13 | 1997-04-02 | Univ Manchester | Wound healing |
EP1051142A4 (de) | 1997-10-16 | 2002-01-30 | Deguang Zhu | Neue kräftige kosmetische oder pharmazeutische zusammensetzung |
AU3635099A (en) | 1997-12-15 | 1999-07-26 | Beth Israel Deaconess Medical Center | Methods and reagents for modulating cell motility |
US6274712B1 (en) * | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
FR2773075B1 (fr) * | 1997-12-31 | 2000-05-05 | Cird Galderma | Utilisation d'activateurs de ppar-gamma en dermatologie |
DE69924232D1 (de) * | 1998-01-09 | 2005-04-21 | Novo Nordisk As | Stabilisierte insulin-zubereitungen |
US6790207B2 (en) | 1998-06-04 | 2004-09-14 | Curon Medical, Inc. | Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract |
US6489306B2 (en) * | 1998-02-23 | 2002-12-03 | University Of South Florida | Method of intranasal gene transfer for protection against respiratory infection |
US6335201B1 (en) | 1998-03-06 | 2002-01-01 | The Regents Of The University Of California | Method and apparatus for detecting enzymatic activity using molecules that change electrophoretic mobility |
BR9909717A (pt) * | 1998-04-17 | 2000-12-26 | Angiogenix Inc | Fatores angiogênicos terapêuticos e métodos para seu uso |
AU4672199A (en) * | 1998-05-20 | 1999-12-06 | Yale University | Modulation of angiogenesis and wound healing |
US6376467B1 (en) * | 1998-10-09 | 2002-04-23 | The Regents Of The University Of California | Use of inhibitors of protein kinase C epsilon to treat pain |
IL141021A0 (en) | 1998-07-23 | 2002-02-10 | Yeda Res & Dev | Treatment of autoimmune conditions with copolymer 1 and related copolymers |
DK2239269T3 (da) | 1998-09-25 | 2013-04-29 | Yeda Res & Dev | Anvendelse af peptider afledt af copolymer-1 som molekylvægtsmarkører |
US6096288A (en) * | 1998-10-12 | 2000-08-01 | Mobil Oil Corporation | Synthesis of the cubic mesoporous molecular sieve MCM-48 |
WO2000030628A2 (en) * | 1998-11-20 | 2000-06-02 | Genentech, Inc. | Method of inhibiting angiogenesis |
CA2382628A1 (en) | 1999-04-14 | 2000-10-19 | The Government Of The United States Of America | Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to a graft |
US7261881B1 (en) * | 1999-05-20 | 2007-08-28 | Yale University | Modulation of angiogenesis and wound healing |
US6541447B1 (en) * | 1999-09-01 | 2003-04-01 | B & M Healthcare Technologies, Inc. | Wound healing composition and method for use thereof |
JP2003523768A (ja) * | 2000-02-25 | 2003-08-12 | イミュネックス・コーポレーション | インテグリンアンタゴニスト |
RU2271222C2 (ru) | 2000-03-24 | 2006-03-10 | Новартис Аг | Улучшенный способ лечения неоваскуляризации |
WO2001076650A1 (en) | 2000-04-06 | 2001-10-18 | University Technology Corporation | Compositions and methods for promoting wound healing |
US20060258562A1 (en) * | 2000-07-31 | 2006-11-16 | Healor Ltd. | Methods and pharmaceutical compositions for healing wounds |
CA2416788A1 (en) * | 2000-07-31 | 2002-02-07 | Tamar Tennenbaum | Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds |
US20100129332A1 (en) | 2000-07-31 | 2010-05-27 | Tamar Tennenbaum | Methods and pharmaceutical compositions for healing wounds |
US20030148924A1 (en) | 2002-07-09 | 2003-08-07 | Tamar Tennenbaum | Methods and pharmaceutical compositions of healing wounds |
US20040037828A1 (en) * | 2002-07-09 | 2004-02-26 | Bar-Ilan University | Methods and pharmaceutical compositions for healing wounds |
US6673603B2 (en) | 2000-09-01 | 2004-01-06 | Modex Therapeutiques, S.A. | Cell paste comprising keratinocytes and fibroblasts |
GB2369572A (en) | 2000-11-29 | 2002-06-05 | Raft Trustees Ltd | Wound treatment composition comprising insulin |
US20020119914A1 (en) * | 2000-12-26 | 2002-08-29 | Deguang Zhu | New uses of insulin and pancreatin |
JP2002198443A (ja) * | 2000-12-26 | 2002-07-12 | Nec Corp | 半導体装置及びその製造方法 |
GB0103877D0 (en) | 2001-02-16 | 2001-04-04 | King S College London | Novel Drug Delivery system |
DE10109280A1 (de) | 2001-02-26 | 2002-09-05 | Peter Mayser | Indolderivate mit inhibitorischer Wirkung auf Proteinkinasen |
DE60229041D1 (de) * | 2001-03-08 | 2008-11-06 | Univ Kentucky Res Found | Verfahren zur erhöhung der leptinspiegel unter verwendung von nikotinsäureverbindungen |
KR100404072B1 (ko) | 2001-03-12 | 2003-11-03 | 주식회사 두산 | 광범위 피부질환 치료용 조성물 |
JP2002272831A (ja) | 2001-03-14 | 2002-09-24 | Fumio Kamiyama | 創傷被覆用粘着性シート |
WO2002087576A1 (en) | 2001-04-30 | 2002-11-07 | Arachnova Therapeutics Ltd. | The treatment of scarring and related conditions using ppar-gamma activators |
WO2002094877A2 (en) | 2001-05-23 | 2002-11-28 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | New nuclear receptor cofactors and related modulators |
ES2184623B1 (es) | 2001-06-29 | 2004-09-16 | Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas (C.I.E.M.A.T.) | Piel artificial autologa secretora de leptina y metodo de obtencion. |
US20030124503A1 (en) | 2001-12-28 | 2003-07-03 | Olivencia-Yurvati Albert H. | Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof |
US6967018B2 (en) * | 2002-01-11 | 2005-11-22 | Applied Genetic Technologies Corporation | Adiponectin gene therapy |
RU2249467C2 (ru) | 2002-11-25 | 2005-04-10 | ООО Научно-производственное предприятие "ЭРЛОН", Лтд. | Медицинский материал и изделия на его основе |
US20040175384A1 (en) * | 2003-12-12 | 2004-09-09 | Mohapatra Shyam S. | Protein kinase C as a target for the treatment of respiratory syncytial virus |
SE0300207D0 (sv) | 2003-01-29 | 2003-01-29 | Karolinska Innovations Ab | New use and composition |
NZ545318A (en) * | 2003-07-15 | 2009-06-26 | Univ Bar Ilan | Pharmaceutical compositions for healing wounds comprising insulin and PKC alpha inhibitor |
EP1646383A4 (de) | 2003-07-21 | 2009-03-25 | Bethesda Pharmaceuticals Inc | Design und synthese von optimierten liganden für ppar |
NZ545086A (en) | 2003-08-07 | 2011-06-30 | Healor Ltd | Pharmaceutical compositions and methods for accelerating wound healing |
WO2005025602A1 (en) | 2003-09-16 | 2005-03-24 | Garvan Institute Of Medical Research | METHODS FOR IDENTIFYING MODULATORS OF PROTEIN KINASE C-EPSILON (PKCϵ) AND METHOD OF TREATMENT OF ABERRANT GLUCOSE METABOLISM ASSOCIATED THEREWITH |
KR20060127415A (ko) | 2003-12-24 | 2006-12-12 | 와이어쓰 | 천식의 치료방법 |
WO2006086681A2 (en) | 2005-02-09 | 2006-08-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of inhibiting smooth muscle cell migration and proliferation |
EP1877424A4 (de) | 2005-04-11 | 2010-09-29 | Pharmagap Inc | Inhibitoren von proteinkinasen und anwendungen davon |
CA2659961A1 (en) | 2005-08-05 | 2007-02-15 | Pharmagap Inc. | Targeted protein kinase c inhibitors and uses thereof |
US8367606B2 (en) | 2005-08-29 | 2013-02-05 | Healor Ltd. | Method and compositions for prevention and treatment of diabetic and aged skin |
WO2007075911A2 (en) | 2005-12-22 | 2007-07-05 | Yale University | Inhibition of glycogen synthase kinase and methods of treating autoimmune or immune inflammatory disease |
WO2008026018A1 (en) | 2006-09-01 | 2008-03-06 | Topotarget Switzerland Sa | New method for the treatment of inflammatory diseases |
US20080292726A1 (en) | 2007-01-23 | 2008-11-27 | Bernstein Lawrence R | Ophthalmic gallium compositions and methods of their use |
CN101835486B (zh) | 2007-07-30 | 2012-12-12 | 希尔洛有限公司 | 用于治疗创伤的药物组合物以及相关方法 |
US8506944B2 (en) | 2008-05-07 | 2013-08-13 | The Regents Of The University Of California | Replenishment and enrichment of ocular surface lubrication |
CN102186822A (zh) | 2008-08-29 | 2011-09-14 | 顶标公司 | 新脲和硫脲衍生物 |
EP2323637A1 (de) | 2008-09-09 | 2011-05-25 | University of East Anglia | Behandlung von fibrotischen augenerkrankungen |
NZ600583A (en) | 2009-02-24 | 2013-08-30 | Healor Ltd | Visfatin therapeutic agents for the treatment of acne and other conditions |
CA2789972A1 (en) | 2010-01-11 | 2011-07-14 | Healor Ltd. | Method for treatment of inflammatory disease and disorder |
-
2004
- 2004-08-05 NZ NZ545086A patent/NZ545086A/en not_active IP Right Cessation
- 2004-08-05 ES ES04745067T patent/ES2375565T3/es active Active
- 2004-08-05 AT AT04745067T patent/ATE529125T1/de active
- 2004-08-05 JP JP2006522494A patent/JP4668902B2/ja not_active Expired - Fee Related
- 2004-08-05 AU AU2004263009A patent/AU2004263009B2/en not_active Ceased
- 2004-08-05 CA CA2535029A patent/CA2535029C/en not_active Expired - Fee Related
- 2004-08-05 DK DK04745067.1T patent/DK1651161T3/da active
- 2004-08-05 ZA ZA200601089A patent/ZA200601089B/en unknown
- 2004-08-05 WO PCT/IL2004/000727 patent/WO2005013885A2/en active Application Filing
- 2004-08-05 CN CN200480029538XA patent/CN101287483B/zh not_active Expired - Fee Related
- 2004-08-05 EP EP04745067A patent/EP1651161B1/de not_active Not-in-force
- 2004-08-05 CN CN2011100370876A patent/CN102120031B/zh not_active Expired - Fee Related
- 2004-08-05 RU RU2006106909/15A patent/RU2358753C2/ru not_active IP Right Cessation
-
2006
- 2006-02-07 US US11/348,527 patent/US7638484B2/en not_active Expired - Fee Related
- 2006-10-31 HK HK06111955.4A patent/HK1091400A1/xx not_active IP Right Cessation
-
2008
- 2008-01-18 US US12/009,567 patent/US20080159978A1/en not_active Abandoned
-
2009
- 2009-02-06 RU RU2009103919/15A patent/RU2419441C2/ru not_active IP Right Cessation
-
2010
- 2010-11-29 JP JP2010264697A patent/JP2011068663A/ja active Pending
-
2011
- 2011-09-01 US US13/224,311 patent/US8507431B2/en not_active Expired - Fee Related
- 2011-10-12 HK HK11110837.3A patent/HK1156515A1/xx not_active IP Right Cessation
-
2013
- 2013-06-24 US US13/924,929 patent/US20140148389A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2535029C (en) | 2013-07-16 |
US20140148389A1 (en) | 2014-05-29 |
RU2419441C2 (ru) | 2011-05-27 |
CN101287483B (zh) | 2012-02-29 |
US7638484B2 (en) | 2009-12-29 |
ES2375565T3 (es) | 2012-03-02 |
JP4668902B2 (ja) | 2011-04-13 |
AU2004263009A1 (en) | 2005-02-17 |
CN102120031A (zh) | 2011-07-13 |
CN101287483A (zh) | 2008-10-15 |
US20120020917A1 (en) | 2012-01-26 |
HK1156515A1 (en) | 2012-06-15 |
AU2004263009B2 (en) | 2009-12-24 |
NZ545086A (en) | 2011-06-30 |
US20060177418A1 (en) | 2006-08-10 |
EP1651161A4 (de) | 2009-09-09 |
CN102120031B (zh) | 2012-12-05 |
RU2358753C2 (ru) | 2009-06-20 |
JP2011068663A (ja) | 2011-04-07 |
US20080159978A1 (en) | 2008-07-03 |
RU2009103919A (ru) | 2010-08-20 |
JP2007512226A (ja) | 2007-05-17 |
DK1651161T3 (da) | 2012-01-30 |
EP1651161A2 (de) | 2006-05-03 |
US8507431B2 (en) | 2013-08-13 |
WO2005013885A3 (en) | 2008-05-02 |
ZA200601089B (en) | 2007-05-30 |
EP1651161B1 (de) | 2011-10-19 |
CA2535029A1 (en) | 2005-02-17 |
RU2006106909A (ru) | 2006-09-10 |
HK1091400A1 (en) | 2007-01-19 |
WO2005013885A2 (en) | 2005-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE529125T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung | |
CY1118179T1 (el) | Φαρμακευτικη συνθεση | |
DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
TW200600087A (en) | Methods and compositions for treating amyloid-related diseases | |
MXPA05013977A (es) | Metodos y composiciones para tratar enfermedades relacionadas con amiloide. | |
UY28215A1 (es) | Quinazolinas utiles como moduladores de canales iónicos | |
EA201000491A1 (ru) | Аминометилзамещенные тетрациклиновые соединения | |
ATE455463T1 (de) | Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren | |
NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
ATE482966T1 (de) | Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide | |
ATE498395T1 (de) | Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung | |
ATE350377T1 (de) | Substituierte 3-pyrrolidin-indol-derivate | |
ATE450251T1 (de) | Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung | |
BRPI0518228A (pt) | inibidores de cinesina mitótica e métodos de uso destes | |
ATE495735T1 (de) | Verfahren und zusammensetzung, die immunomodulatorische verbindungen zur behandlung von mit niedrigen plasmaleptin-spiegeln in zusammenhang stehenden störungen verwenden | |
CY1113116T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
DE602006008583D1 (de) | Stabile kristalline form von bifeprunoxmesylat, dosierungsformen davon und verfahren zu deren verwendung | |
ATE497763T1 (de) | Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen | |
BRPI0507859A (pt) | uso dos inibidores da colinesterase | |
DK1638582T3 (da) | Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after | |
BRPI0507157A (pt) | uso de fator viia ou de um equivalente de fator viia, kit de partes para tratamento de trauma, e, métodos para tratar trauma e para prevenir, tratar trauma | |
ATE503476T1 (de) | Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind | |
CY1110156T1 (el) | Υποκατεστημενες ενωσεις 4,5,6,7-τετραϋδρο-βενζοθειαζολ-2-υλαμινης | |
ATE478156T1 (de) | Verfahren zur identifizierung von modulatoren der eoxin-bildung | |
DE602006016413D1 (de) | Kim-1-antikörper zur behandlung von th2-vermittelten erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1651161 Country of ref document: EP |